Fig. 1: Analysis of biochemical indicators and intestinal FXR signaling in SBS patients. | Communications Biology

Fig. 1: Analysis of biochemical indicators and intestinal FXR signaling in SBS patients.

From: Lactobacillus rhamnosus GG maintains gut microbiota stability and promotes intestinal adaptation via activated intestinal farnesoid X receptor signaling in short bowel syndrome

Fig. 1

a Alterations in plasma biochemical parameters between SBS and control groups. b mRNA expressions of FXR and its downstream targets in the intestine, including I-BABP, OST-α and OST-β between SBS patients and controls. *P < 0.05, **P < 0.01.

Back to article page